IMNM
Immunome Inc
NASDAQ: IMNM · HEALTHCARE · BIOTECHNOLOGY
$22.95
-3.21% today
Updated 2026-04-29
Market cap
$2.60B
P/E ratio
—
P/S ratio
374.45x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$7 – $28
Volume
1.2M
Immunome Inc (IMNM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.41M | $-9.60M | $-12.13M | $-18.23M | $-28.69M | $-7.57M | $-110.79M | $-190.92M |
| Capital expenditures | $228000.00 | $233000.00 | $586000.00 | $79000.00 | $248000.00 | $831000.00 | $53.51M | $9.69M |
| Depreciation | $521000.00 | $615000.00 | $755000.00 | $755000.00 | $631000.00 | $728000.00 | $2.10M | — |
| Stock-based comp | $11000.00 | $14000.00 | $621000.00 | $3.45M | $5.33M | $6.22M | $15.75M | $25.69M |
| Free cash flow | $-7.63M | $-9.83M | $-12.72M | $-18.30M | $-28.94M | $-8.40M | $-164.30M | $-200.60M |
| Investing cash flow | $-228000.00 | $-233000.00 | $-586000.00 | $-79000.00 | $-248000.00 | $-30.48M | $-85.06M | — |
| Financing cash flow | $-551000.00 | $10.77M | $49.94M | $27.77M | $32000.00 | $116.41M | $240.53M | — |
| Dividends paid | — | $4.62M | $49000.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $37.22M | — | $-28.91M | — | — | — |